Furthermore, the CCRI biomarker candidates for gastric tumours, reported herein, particularly IL1RAP, are likely to help in the development of less invasive and more accurate diagnostic and potentially therapeutic modality. This evidence concerns the gene IL1RAP and gastric neoplasm.